Related Experiment Video
Updated: Mar 30, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Immunotherapy for Head and Neck Squamous Cell Carcinoma.
David W Schoppy1, John B Sunwoo1
1Division of Head and Neck Surgery, Department of Otolaryngology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Recent head and neck squamous cell carcinoma (HNSCC) research shows promising immunotherapy results. New strategies like immune checkpoint blockade and engineered T cells are being explored in early clinical trials.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Head and neck squamous cell carcinoma (HNSCC) was historically viewed as non-immunogenic.
- Emerging clinical data suggests HNSCC may respond to immunotherapeutic interventions.
Purpose of the Study:
- To review current advancements in HNSCC immunotherapy.
- To highlight novel therapeutic strategies and ongoing clinical trials.
Main Methods:
- Review of recent clinical studies on immune checkpoint blockade in HNSCC.
- Discussion of other immunotherapy approaches including antibody-dependent cell-mediated cytotoxicity enhancement, tumor vaccines, and adoptive T cell therapy.
Main Results:
- Immune checkpoint blockade strategies have shown renewed promise in HNSCC treatment.
- Several novel immunotherapy approaches are currently in early-phase clinical trials.
Conclusions:
- Immunotherapy holds significant potential for treating head and neck squamous cell carcinoma.
- Ongoing clinical trials are expected to yield exciting results in the near future.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers

